Results 61 to 70 of about 244,949 (162)
An overview on Anti-Vegf and in search for an ideal anti VEGF agent
Indian Journal of Clinical and Experimental Ophthalmology, 2022 openaire +1 more source
Brolucizumab—another anti-VEGF or beyond [PDF]
Eye, 2020 Sharma, Ashish +6 more
openaire +4 more sources
Anti-VEGF drugs in the prevention of blindness.
Community eye health, 2014 Disorders of the blood vessels in the retina are responsible for some of the most common causes of blindness in the world.
openaire +2 more sources
Anti – VEGF in Treatment of Diabetic Macular Edema
Collegium antropologicum, 2012 Diabetic macular edema is the leading cause of moderate visual deterioration in patients with diabetic retinopathy. Ranibizumab) blocks vascular endothelial growth factor (VEGF) induced hyperpermeability of blood vessels. In this prospective case series we investigated the efficacy and safety of anti-VEGF treatment in reduction of central retinal ...
Boras, Ivan +4 more
openaire +3 more sources
Neovascular age-related macular degeneration management - Beyond anti-VEGF. [PDF]
Indian J OphthalmolAyachit A +7 more
europepmc +1 more source
Anti-VEGF therapy for posterior segment disorders: The story so far…. [PDF]
Indian J OphthalmolChawla R.
europepmc +1 more source
Optimizing the invisible costs of anti-VEGF: The road to regularity. [PDF]
Indian J OphthalmolAgrawal S.
europepmc +1 more source
Anti-VEGF versus laser photocoagulation for ROP treatment. [PDF]
BioinformationUkey S +4 more
europepmc +1 more source
Systemic and ocular complications related to intravitreal administration of anti-VEGF agents. [PDF]
Med Hypothesis Discov Innov OphthalmolKoksaldi S +3 more
europepmc +1 more source